About this episode
n this conversation with plant scientist and commercial cultivation strategist Dr. Matthew Indest, we explore the emerging frontier of seed-based cannabis production and what it would take for the industry to move beyond clonal propagation.We cover:The agronomic upside of seed-grown plants (disease resistance, vigor, adaptability, cost savings)The scientific and operational barriers preventing widespread seed adoptionHow genetic stability, inbreeding depression, and trait selection differ between cannabis and traditional cropsData-driven cultivation strategies for evaluating new seed linesWhether seed-based production can truly rival clonal systems for consistency and top-tier flower qualityWhat the next decade of cannabis breeding and cultivation might look likeAbout Dr. Indest:Matthew holds a Ph.D. in plant science and has spent more than a decade bridging academic research with applied cannabis production. He has led breeding and cultivation programs across indoor, greenhouse, and outdoor operations and focuses on developing high-performing cultivars and integrated, data-backed production systems. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
